Abbrea Capital’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
$8.67M Sell
9,579
-75
-0.8% -$67.9K 1.15% 24
2024
Q1
$7.51M Buy
9,654
+228
+2% +$177K 0.99% 26
2023
Q4
$5.5M Buy
9,426
+383
+4% +$223K 0.79% 30
2023
Q3
$4.86M Sell
9,043
-218
-2% -$117K 0.77% 32
2023
Q2
$4.34M Buy
9,261
+172
+2% +$80.7K 0.67% 36
2023
Q1
$3.12M Sell
9,089
-130
-1% -$44.7K 0.53% 49
2022
Q4
$3.37M Buy
9,219
+98
+1% +$35.9K 0.61% 44
2022
Q3
$2.95M Sell
9,121
-142
-2% -$45.9K 0.56% 43
2022
Q2
$3M Buy
9,263
+30
+0.3% +$9.73K 0.5% 51
2022
Q1
$2.64M Hold
9,233
0.37% 62
2021
Q4
$2.55M Buy
9,233
+338
+4% +$93.4K 0.34% 64
2021
Q3
$2.06M Sell
8,895
-252
-3% -$58.2K 0.31% 72
2021
Q2
$2.1M Buy
9,147
+220
+2% +$50.5K 0.32% 70
2021
Q1
$1.67M Buy
8,927
+167
+2% +$31.2K 0.28% 79
2020
Q4
$1.48M Buy
8,760
+23
+0.3% +$3.88K 0.26% 77
2020
Q3
$1.29M Sell
8,737
-277
-3% -$41K 0.27% 79
2020
Q2
$1.48M Buy
9,014
+116
+1% +$19K 0.34% 72
2020
Q1
$1.23M Buy
8,898
+1,083
+14% +$150K 0.33% 72
2019
Q4
$1.03M Sell
7,815
-45
-0.6% -$5.91K 0.22% 95
2019
Q3
$879K Buy
7,860
+2,430
+45% +$272K 0.2% 100
2019
Q2
$602K Sell
5,430
-106
-2% -$11.8K 0.15% 120
2019
Q1
$718K Buy
5,536
+601
+12% +$77.9K 0.21% 102
2018
Q4
$571K Buy
4,935
+225
+5% +$26K 0.19% 106
2018
Q3
$505K Buy
4,710
+635
+16% +$68.1K 0.15% 116
2018
Q2
$348K Sell
4,075
-178
-4% -$15.2K 0.11% 131
2018
Q1
$329K Buy
4,253
+1,593
+60% +$123K 0.11% 136
2017
Q4
$225K Buy
2,660
+197
+8% +$16.7K 0.08% 149
2017
Q3
$211K Hold
2,463
0.08% 149
2017
Q2
$203K Buy
2,463
+60
+2% +$4.95K 0.08% 143
2017
Q1
$202K Buy
+2,403
New +$202K 0.08% 140